{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Prostate Cancer, Androgen Deprivation Therapy, and Cardiovascular Risk","description":" Androgen deprivation therapy (ADT) remains foundational in the treatment of prostate cancer. However, prolonged and intensified use of ADT is associated with clinically meaningful cardiovascular (CV) toxicity. This course reviews the major classes of ADT, their mechanisms of action, and the biological pathways linking androgen suppression to CV risk, with emphasis on metabolic dysfunction, vascular injury, and thrombotic risk. Learners will gain practical insight into integrating cardiovascular considerations into prostate cancer management.  Claim CE credit: https:\/\/bit.ly\/4BmSo0l ","author_name":"HeartBEATS from Lifelong Learning\u2122","author_url":"https:\/\/professional.heart.org\/professional\/EducationMeetings\/UCM_475320_Education-Meetings.jsp","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/43462984\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/43462984"}